This study is designed to assess how rapidly and how safely Clevidipine can be used to control high Blood Pressure in patients with subarachnoid hemorrhage which is a type of brain bleed that happens because of a weak balloon like structure in one of the brain vessels. Control of blood pressure is of high value in preventing this balloon that ruptured and bled from rebleeding. The ultimate cure would be to shut down the aneurysm by a surgical procedure. Clevidipine is a drug that can lower blood pressure and it is given through the vein as a continuous infusion. It is a very short acting drug which is important in controlling labile blood pressure condition with rapid changes between up and down. This trial will test for its rapid actions and check for any side effects and possibly any other potential benefit.
Who can participate
Age range18 Years – 80 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria
✓. Diagnosis of SAH
✓. Presence of unsecured aneurysm
✓. Patient age between 18 and 80 years
✓. Hunt and Hess grade \<5 (non-sedated-paralyzed pt)
✓. Glasgow Coma scale \>4 (non-sedated-paralyzed pt)
✓. BP above the pre-specified upper limit set by MD
✓. Patient has not received pressors or inotropes
✓. Patient has not received IV anti-hypertensives for more than 5 minutes (sodium nitroprusside infusion should be stopped as clevidipine is started
Exclusion criteria
✕. Patient is \<18 or \>80 years of age
✕. Patient has Traumatic SAH
✕. Patient has Perimesencephalic SAH
What they're measuring
1
Ability to Control and Maintain Blood Pressure Within a Certain Range by the Drug Infusion.